PTC
KRYS icon

Private Trust Company’s Krystal Biotech KRYS Stock Holding History

Private Trust Company’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86K Buy
+5
New +$1.49K ﹤0.01% 2511
2024
Q1 		– Sell
-32
Closed -$3.97K – 2304
2023
Q4 		$3.97K Buy
32
+9
+39% +$998 ﹤0.01% 2003
2023
Q3 		$2.67K Buy
+23
New +$2.81K ﹤0.01% 2062

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Private Trust Company's KRYS Position: Q2 2026 in Review

Private Trust Company opened a new position in Krystal Biotech (KRYS) in Q2 2026: 5 shares worth $1.86K. The stake represents ﹤0.01% of the portfolio and ranks #2511 among its holdings. This is a return to the name: Private Trust Company previously reported a position in KRYS as recently as Q4 2023.

Private Trust Company first reported a position in KRYS in Q3 2023 and has held it in 3 quarters since. The position peaked at $3.97K in Q4 2023. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Private Trust Company held 5 shares of Krystal Biotech worth $1.86K as of Q2 2026.
  • Krystal Biotech was a new Private Trust Company position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2511 holding.
  • Private Trust Company first reported a position in Krystal Biotech in Q3 2023 and has held it in 3 quarters since.
  • Private Trust Company's Krystal Biotech position peaked at $3.97K in Q4 2023.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.